Altered blood parameters in “major depression” patients receiving repetitive transcranial magnetic stimulation (rTMS) therapy: a randomized case-control study

dc.authorid0000-0002-2306-5937
dc.contributor.authorÖzkan, Beyza Nur
dc.contributor.authorBozali, Kübra
dc.contributor.authorBoylu, Muhammed Emin
dc.contributor.authorVelioğlu, Halil Aziz
dc.contributor.authorAktaş, Selman
dc.contributor.authorKırpınar, İsmet
dc.contributor.authorGüler, Eray Metin
dc.date.accessioned2024-07-02T06:02:10Z
dc.date.available2024-07-02T06:02:10Z
dc.date.issued2024
dc.departmentİstanbul Medipol Üniversitesi, Sağlık Bilimleri Enstitüsü, Sinirbilim Ana Bilim Dalı
dc.description.abstractMajor depressive disorder (MDD) is a debilitating illness that includes depressive mood. Repetitive Transcranial Magnetic Stimulation (rTMS) is a therapy method used in the treatment of MDD. The purpose of this study was to assess neurotrophic factors, and oxidative stress levels in MDD patients and evaluate the changes in these parameters as a result of rTMS therapy. Twenty-five patients with MDD and twenty-six healthy volunteers with the same demographic characteristics were included in the study. Brain-derived neurotrophic factors were measured photometrically with commercial kits. Oxidative stress parameters were measured by the photometric method. Oxidative stress index (OSI) and disulfide (DIS) levels were calculated with mathematical formulas. In this study, total antioxidant status (TAS), total thiol (TT), and native thiol (NT) antioxidant parameters and brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), and allopregnanolone (ALLO) levels were reduced in pre-rTMS with regard to the healthy control group; TOS, OSI, DIS, and S100 calcium-binding protein B (S100B) levels were increased statistically significantly (p < 0.01). Moreover, owing to TMS treatment; TAS, TT, NT, BDNF, GDNF, and ALLO levels were increased compared to pre-rTMS, while DIS, TOS, OSI, and S100B levels were decreased significantly (p < 0.01). The rTMS treatment reduces oxidative stress and restores thiol-disulfide balance in MDD patients. Additionally, rTMS modulates neurotrophic factors and neuroactive steroids, suggesting its potential as an antidepressant therapy. The changes in the biomarkers evaluated may help determine a more specific approach to treating MDD with rTMS therapy.
dc.identifier.citationÖzkan, B. N., Bozali, K., Boylu, M. E., Velioğlu, H. A., Aktaş, S., Kırpınar, İ. ... Güler, E. M. (2024). Altered blood parameters in “major depression” patients receiving repetitive transcranial magnetic stimulation (rTMS) therapy: a randomized case-control study. Translational Psychiatry, 14(1). http://dx.doi.org/10.1038/s41398-024-02942-8
dc.identifier.doi10.1038/s41398-024-02942-8
dc.identifier.issn2158-3188
dc.identifier.issue1
dc.identifier.pmid38918365
dc.identifier.scopus2-s2.0-85196860229
dc.identifier.scopusqualityQ1
dc.identifier.urihttp://dx.doi.org/10.1038/s41398-024-02942-8
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12683
dc.identifier.volume14
dc.identifier.wos001254808200001en_US
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorVelioğlu, Halil Aziz
dc.language.isoen
dc.relation.ispartofTranslational Psychiatryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMajor Depressive Disorder
dc.subjectMDD
dc.subjectRepetitive Transcranial Magnetic Stimulation
dc.subjectrTMS
dc.titleAltered blood parameters in “major depression” patients receiving repetitive transcranial magnetic stimulation (rTMS) therapy: a randomized case-control study
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Velioğlu-Halil Aziz-2024.pdf
Boyut:
449.8 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: